No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Sophia Genetics Analyst Ratings
Craig-Hallum Initiates Sophia Genetics(SOPH.US) With Buy Rating, Announces Target Price $11
SOPHiA GENETICS Announced The Global Launch Of MSK-impact Powered With Sophia DDM From The Association For Molecular Pathology Annual Meeting
Morgan Stanley Maintains Sophia Genetics(SOPH.US) With Hold Rating, Maintains Target Price $5
Morgan Stanley Sticks to Its Hold Rating for SOPHiA GENETICS (SOPH)
Earnings Call: SOPHiA GENETICS Reported A16% Year-over-year Increase in Analysis Volume